Literature DB >> 23395317

The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.

Chistopher Burke1, Lee Alexander Grant, Vicky Goh, Nyree Griffin.   

Abstract

Hepatocyte-specific contrast agents have been made available in the last 15 years for magnetic resonance imaging of the liver. These agents are differentially taken up by functioning hepatocytes and excreted in the biliary system. They can help distinguish focal liver lesions of hepatocellular origin from lesions of nonhepatocellular origin, and can also be used in the evaluation of the biliary tree. The purpose of this review is to summarize the different types of hepatocyte-specific contrast agents presently available, their use in the characterization of focal liver lesions, their role in the evaluation of biliary pathology, and their potential future applications.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23395317     DOI: 10.1053/j.sult.2012.11.004

Source DB:  PubMed          Journal:  Semin Ultrasound CT MR        ISSN: 0887-2171            Impact factor:   1.875


  7 in total

Review 1.  Hepatocyte-specific contrast media: not so simple.

Authors:  Andrew T Trout; Alexander J Towbin; Ethan A Smith; Anita Gupta; Jonathan R Dillman
Journal:  Pediatr Radiol       Date:  2018-08-04

2.  Manganese-Enhanced Magnetic Resonance Imaging as a Diagnostic and Dispositional Tool after Mild-Moderate Blast Traumatic Brain Injury.

Authors:  Olga Rodriguez; Michele L Schaefer; Brock Wester; Yi-Chien Lee; Nathan Boggs; Howard A Conner; Andrew C Merkle; Stanley T Fricke; Chris Albanese; Vassilis E Koliatsos
Journal:  J Neurotrauma       Date:  2015-12-14       Impact factor: 5.269

3.  Primary hepatic neuroendocrine tumors: comparing CT and MRI features with pathology.

Authors:  Li-Xia Wang; Kan Liu; Guang-Wu Lin; Tao Jiang
Journal:  Cancer Imaging       Date:  2015-08-15       Impact factor: 3.909

4.  Assessment of MRI Contrast Agent Kinetics via Retro-Orbital Injection in Mice: Comparison with Tail Vein Injection.

Authors:  Fang Wang; Masanori Nojima; Yusuke Inoue; Kuni Ohtomo; Shigeru Kiryu
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 5.  The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.

Authors:  Woo Kyoung Jeong; Young Kon Kim; Kyoung Doo Song; Dongil Choi; Hyo Keun Lim
Journal:  Clin Mol Hepatol       Date:  2013-12-28

6.  Imaging features of biliary adenofibroma of the liver with malignant transformation: a case report with literature review.

Authors:  Wenjun Hu; Ying Zhao; Yunsong Liu; Zhengyu Hua; Ailian Liu
Journal:  BMC Med Imaging       Date:  2022-03-17       Impact factor: 1.930

7.  Biliary complications following orthotopic liver transplantation: May contrast-enhanced MR Cholangiography provide additional information?

Authors:  Piero Boraschi; Francescamaria Donati; Roberto Gigoni; Franco Filipponi
Journal:  Eur J Radiol Open       Date:  2016-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.